Close Menu
Home › NeoGenomics Downgraded to Equal-Weight by First Analysis

NeoGenomics Downgraded to Equal-Weight by First Analysis

May 02, 2018

NEW YORK (360Dx) – First Analysis Securities today downgraded NeoGenomics to Equal-Weight from Overweight based on the company's valuation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Apr
09
Featured Webinar

Combining AI with Community-Driven Insights: Advanced Diagnosis of Inherited Cardiac Diseases

Sponsored by
Sophia Genetics

This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies. 

Apr
30
Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

What's Popular?

In Clinical Lab Management

  1. Lab Organizations Ask CMS to Withdraw Coding Guideline Updates

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.